Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Lis William
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Eidos Therapeutics, Inc.
Jasper Therapeutics, Inc.
Portola Pharmaceuticals Inc
Zai Lab Ltd
Portola Pharmaceuticals Inc
Chief Executive Officer, Director
Avg. Two Year Performance
No Purchase Track Record
6%
Avg. Sale Return
3%
Compound
Holdings:
204.45K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions